Clinical distribution of anticentromere antibody in Japanese patients.
Serum samples from 401 subjects were screened for the presence of anticentromere antibody using HEp-2 cells as the substrate for an indirect immunofluorescence method. Anticentromere antibody was found in 16 cases; 8 out of 62 patients with systemic sclerosis, 3 out of 7 patients with primary Raynaud's disease, 2 out of 41 patients with systemic lupus erythematosus, 1 out of 54 asymptomatic relatives of systemic sclerosis and 2 out of 50 patients with miscellaneous diseases. In systemic sclerosis, the patients with anticentromere antibody were limited in CREST (calcinosis, Raynaud's phenomenon, esophageal involvement, sclerodactylia and telangiectasia) variant. As reported previously by many investigators, anticentromere antibody is considered as a useful immunologic marker for CREST variant of systemic sclerosis, although this antibody is widely distributed in other conditions with less frequency.
Soma
Y
Y
Department of Dermatology, Faculty of Medicine, University of Tokyo, Japan.
Takehara
K
K
Ishibashi
Y
Y
D001323:Autoantibodies / Q000032:analysis*; D002503:Centromere / Q000276:immunology*; D002875:Chromosomes / Q000276:immunology*; D003593:Cytoplasm / Q000276:immunology; D003882:Dermatomyositis / Q000175:diagnosis*; D005455:Fluorescent Antibody Technique; D006801:Humans; D008178:Lupus Erythematosus, Cutaneous / Q000175:diagnosis*; D011928:Raynaud Disease / Q000175:diagnosis*; D012594:Scleroderma, Localized / Q000175:diagnosis*; D012595:Scleroderma, Systemic / Q000175:diagnosis*; D012867:Skin / Q000276:immunology
D001323:Autoantibodies